Cyclerion Stock Soars on $380M Merger with Korsana to Fight Alzheimer’s
Cyclerion stock surges after announcing a merger with Korsana Biosciences and $380M in new funding to advance a next-gen Alzheimer’s antibody.
/ 1 item
#KRSA↓